Login Register
English
0

Cart

$ 0

β-Sitosterol enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma via the FXR/LXR/SREBP1/FASN pathway(KTA2030-4.1)

Date:2026-03-03 Views:54